Tango Therapeutics, Inc.
TNGX
Revenue
19.88M
▲13.40M▲207.14%
3 Months ChangeAssets
381.45M
▼-24.77M▼-6.10%
3 Months ChangeLiabilities
133.78M
▼-7.99M▼-5.64%
3 Months ChangeFree Cash Flow
-38.05M
▼-2.53M▼-7.11%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-08-07
Form 10-Q
ID: 0000950170-24-092274
2024-08-07
Form 8-K
ID: 0000950170-24-092270
2024-06-06
Form 8-K
ID: 0001193125-24-156048
2024-05-23
Form 8-K
ID: 0001193125-24-145434
2024-05-08
Form 10-Q
ID: 0000950170-24-055065
2024-05-08
Form 8-K
ID: 0000950170-24-055062
2024-03-18
Form 8-K
ID: 0000950170-24-032513
2024-02-07
Form 8-K
ID: 0001193125-24-025907
2023-11-08
Form 10-Q
ID: 0000950170-23-060682
2023-11-08
Form 8-K
ID: 0000950170-23-060671